All the CpG sites, including five each recognized by the MS-PCR primers for PCDHA4 and PCDHA13, were hypermethylated in the SCC or CIS samples, whereas low methylation densities were noted in the normal samples. This evidence concerns the gene PCDHA13 and in situ carcinoma.